The response of a patient with Langerhans Cell Histiocytosis (LCH) to therapy can be classified into semi-quantitative categories (LCH III).
Patient selection: Langerhans Cell Histiocytosis ay 6 weeks after therapy
General Category
Response
Alternative
better
complete resolution
non-active
regression
active disease-better
interrmediate
mixed
active-mixed
intermediate
stable
active-unchanged
worse
active disease-worse
Mixed: regression in one site AND progression in another
Stable: neither regression nor progression
Worse: progression of signs and symptoms and/or appearance of new lesions
Existing Lesions
New Lesions
Signs and Symptoms
inactive
none
active-better
present
unchanged
progression
NA
active-worse
To read more or access our algorithms and calculators, please log in or register.
Specialty: Hematology Oncology
